Rate of persistence on treatment after 6,12, and 24 months in different subgroups of patients treated with angiotension-II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), lercanidipine, ß-blockers, and diuretics. *, **, ***p < 0.05, 0.01, 0.005 vs ARBs.